BiotechTube
Home/FcR Therapeutics/Geert van Tetering, PhD
GV

Geert van Tetering, PhD

Chief Operating Officer & Chief Scientific Officer

FcR Therapeutics

Therapeutic Areas

Autoimmune Diseases

FcR Therapeutics Pipeline

DrugIndicationPhase
Undisclosed FcR-targeting Nanobody Program(s)Autoimmune DiseasesPre-clinical

Leadership Team at FcR Therapeutics

GM
Guido Maertens, MSc
Chief Executive Officer & Chief Financial Officer
MD
Mark de Boer, PhD
Senior Vice President Corporate Development
View full FcR Therapeutics profile